Search Results - "Mastboom, M.J.L."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Treatments of tenosynovial giant cell tumours of the temperomandibular joint: a report of three cases and a review of literature by Verspoor, F.G.M., Mastboom, M.J.L., Weijs, W.L.J., Koetsveld, A.C., Schreuder, H.W.B., Flucke, U.

    “…Tenosynovial giant cell tumours (TGCTs) are benign lesions affecting synovial joints. The classified subtypes are localized and diffuse. They seldom occur in…”
    Get full text
    Journal Article
  3. 3

    The effect of Imatinib Mesylate in diffuse-type Tenosynovial Giant Cell Tumours on MR imaging and PET-CT by Mastboom, M.J.L., Lips, W., van Langevelde, K., Mifsud, M., Ng, C., McCarthy, C.L., Athanasou, N.A., Gibbons, C.L.M.H., van de Sande, M.A.J.

    Published in Surgical oncology (01-12-2020)
    “…Recurrence rates remain high after surgical treatment of diffuse-type Tenosynovial Giant Cell Tumour (TGCT). Imatinib Mesylate (IM) blocks Colony Stimulating…”
    Get full text
    Journal Article
  4. 4

    Severity classification of Tenosynovial Giant Cell Tumours on MR imaging by Mastboom, M.J.L., Verspoor, F.G.M., Hanff, D.F., Gademan, M.G.J., Dijkstra, P.D.S., Schreuder, H.W.B., Bloem, J.L., van der Wal, R.J.P., van de Sande, M.A.J.

    Published in Surgical oncology (01-09-2018)
    “…Current development of novel systemic agents requires identification and monitoring of extensive Tenosynovial Giant Cell Tumours (TGCT). This study defines…”
    Get full text
    Journal Article